Women who use a hormone-releasing intrauterine device, or IUD, face around the same risk of breast cancer as women who take ...

During follow-up of almost 7 years, hormone-releasing IUD use conferred a 40% higher risk of breast cancer. The data showed a ...

Intrauterine Devices Market Growing consciousness of long-acting reversible contraceptives (LARC) is driving the <a target=_blank href ...

The study found an 'unexpected' association between the use of an intrauterine system, also known as an hormonal coil, and an ...

Democratic lawmakers called on Senate Republicans to pass a bill that would protect and expand access to contraception in ...

If you have any questions, ask your doctor or pharmacist. This device is placed in your uterus by a health care provider during an in-office visit. It is left in place for up to 8 years.

See related article at KEY POINTS Early pregnancy loss is common and often devastating. Adverse medical and psychological complications may be avoided with the provision of informed, compassionate ...

On Monday, Hologic Inc (NASDAQ:HOLX) agreed to acquire Gynesonics, Inc. for approximately $350 million. Gynesonics is a ...

Hormone replacement therapy will be available at no cost to menopausal women starting in January, but will pharmacies be able ...

Medical device manufacturer Hologic is broadening its focus on women’s health as the Marlborough-based firm has signed a ...

Iowa is under a near-total abortion ban, and Democratic challenger Lanon Baccam is trying to make it US Rep. Zach Nunn’s ...

"Hologic to acquire Gynesonics to strengthen women’s health portfolio" was originally created and published by Medical Device ...